Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals Inc. is a specialty pharmaceutical company dedicated to the development, manufacture, and marketing of innovative generic and proprietary injectable, inhalation, and intranasal products. Amphastar's primary function is to provide cost-effective medications that improve patient care and accessibility to treatment. The company’s product portfolio includes critical drugs used in hospitals and other medical settings, targeting areas like endocrinology, anesthesia, and pain management. Amphastar Pharmaceuticals impacts the healthcare industry significantly by supplying generic alternatives to high-cost brand-name drugs, greatly aiding healthcare systems in managing medication expenditures. Headquartered in Rancho Cucamonga, California, Amphastar operates both in the United States and internationally, emphasizing rigorous quality control and regulatory compliance in its production processes. The company plays a vital role in the healthcare market by ensuring a steady supply of essential medicines, helping to alleviate shortages and support the delivery of efficient medical care.